PMID: 2113307Jun 1, 1990Paper

The early expression of some human autoantibody-associated heavy chain variable region genes is controlled by specific regulatory elements

Scandinavian Journal of Immunology
P P ChenD A Carson

Abstract

Recent molecular cloning studies have revealed that some autoantibodies may be encoded directly by germline Ig variable (V) genes without any somatic mutation, suggesting strongly that such autoantibodies are physiologically important. Independent analyses of Ig gene expression in a human fetal liver showed that only nine heavy chain V (Vh) genes were used, out of a potential germline Vh gene repertoire of 100-200. We have observed that four of these nine Vh genes encode sequences identical or almost identical to human autoantibody heavy chains. This unexpected overlap implies that some autoantibodies are expressed preferentially during early development. Recent structural analyses of two Vh3 genes expressed in fetal liver revealed many more enhancer-like sequences in the flanking regions than expected for a typical Vh gene. It is hypothesized that these autoantibody-related Vh genes may contain various combinations of cis regulatory elements which influence their specific expression during early ontogenic development. Furthermore, these observations are consistent with network hypotheses, which suggest that early B-cell development is driven by reactivity with self. The cis regulatory elements in the autoantibody genes may act...Continue Reading

References

Jul 1, 1989·European Journal of Immunology·C A PennellS H Clarke
Oct 1, 1989·The Journal of Experimental Medicine·T LogtenbergF W Alt
Jul 14, 1989·Cell·W S Dynan
Jul 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·I LundkvistD Holmberg
Oct 1, 1989·Scandinavian Journal of Immunology·A M CuisinierC Tonnelle
Oct 1, 1988·Immunological Reviews·M ZoualiR S Schwartz
Mar 1, 1988·International Reviews of Immunology·S AvrameasT Ternynck
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·S Eaton, K Calame
Nov 6, 1987·Science·H W SchroederR M Perlmutter
Jul 1, 1988·The Journal of Experimental Medicine·G D YancopoulosF W Alt
Jan 1, 1988·Springer Seminars in Immunopathology·P P ChenD A Carson
Nov 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·H W SchroederR M Perlmutter
Nov 1, 1988·European Journal of Immunology·L Buluwela, T H Rabbitts
Nov 1, 1988·Annales De L'Institut Pasteur. Immunology·A CoutinhoT A Mota-Santos
Dec 1, 1988·Genes & Development·R G ClercP A Sharp
Nov 20, 1987·Science·F W AltG D Yancopoulos
Jul 1, 1986·The Journal of Experimental Medicine·D PortnoïA Coutinho
Mar 29, 1985·Science·R M PerlmutterL E Hood
Nov 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·G Matthyssens, T H Rabbitts
Sep 1, 1984·The Journal of Clinical Investigation·E CairnsD A Bell

❮ Previous
Next ❯

Citations

Feb 1, 1993·The Journal of Experimental Medicine·A K StewartR S Schwartz
Jun 1, 1993·British Journal of Haematology·M DeaneJ D Norton
Aug 1, 1992·Immunological Reviews·A K StewartR S Schwartz
Sep 29, 1995·Annals of the New York Academy of Sciences·B J Stiernholm, N L Berinstein
Apr 25, 1997·Journal of Molecular Biology·O IgnatovichG Winter

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.